Idorsia Ltd (IDRSF) Financials

IDRSF Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 599.8 million 2.1 billion
Dec. 31, 2025 587.2 million 2.0 billion
Sept. 30, 2025 570.1 million 2.0 billion
June 30, 2025 628.1 million 2.1 billion

IDRSF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -35.3 million 3.4 million
Dec. 31, 2025 -58.2 million 2.1 million
Sept. 30, 2025 -26.2 million ?
June 30, 2025 -56.8 million -220719

IDRSF Net Income

No data available :(

IDRSF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 118.2 million 1.5 billion 136.6 million
Dec. 31, 2025 110.0 million 1.5 billion 141.4 million
Sept. 30, 2025 89.3 million 1.4 billion 134.8 million
June 30, 2025 103.6 million 1.2 billion 153.5 million

IDRSF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 315.4 million
Dec. 31, 2025 313.0 million
Sept. 30, 2025 269.3 million
June 30, 2025 237.5 million

IDRSF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 2.0 million 29.6 million 64.2 million -
Dec. 31, 2025 3.6 million 34.7 million 79.8 million -
Sept. 30, 2025 200656 28.3 million 67.5 million -
June 30, 2025 12.3 million 28.6 million 64.4 million -

IDRSF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 71.7 million 10.1 million
Dec. 31, 2025 60.5 million 6.6 million
Sept. 30, 2025 52.0 million 12.3 million
June 30, 2025 91.1 million 4.3 million

IDRSF

Price: $5.75

52 week price:
1.86
5.82

Earnings Per Share: -1.31 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 1.5 billion

Links: